Vericel Denmark ApS: Financial statements 2020
CVR: 19740986
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Vericel Denmark ApS (CVR 19740986) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -83,378 and a net result of DKK -83,448 compared with DKK -33,862 the year before. Equity in the 2020 report amounted to DKK 6,838,845. The solvency ratio was 99.6%.
- Gross Profit
- DKK -83,378
- Profit/Loss
- DKK -83,448
- Equity
- DKK 6,838,845
- Total Assets
- DKK 6,864,261
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -83 t. | -83 t. | 6.8 mio. | 0 |
| 2019 | - | -33 t. | -34 t. | 6.9 mio. | 0 |
| 2018 | - | -86 t. | -91 t. | 7 mio. | 0 |
| 2017 | - | 9 t. | 9 t. | 7 mio. | 0 |
| 2016 | - | -221 t. | -1.3 mio. | 7 mio. | 0 |
Official annual report
How creditworthy is Vericel Denmark ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of September 30, 2020, Gerard Joseph Michel has stepped down as director of Vericel Denmark ApS.
As of September 5, 2020, Sandra Lynn Pennell is registered as director of Vericel Denmark ApS.
Vericel Denmark ApS has published its annual report for 2019. Gross profit came to DKK -32,977, and the net result was DKK -33,862.
About Vericel Denmark ApS
Vericel Denmark ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 1996. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named AASTROM BIOSCIENCES DK ApS and GENZYME BIOSURGERY ApS. The management consists of Joseph Anthony Mara Jr. The company is owned by Vericel Corporation. The company has 0 employees (2015). In 2025, the company reported a gross profit of DKK -128,481 and a net result of DKK -128,481 compared with DKK -109,464 the year before. Equity in the 2025 report amounted to DKK 6,241,335.